Hyponatremia screening: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{Saeedeh}} | {{CMG}}; {{AE}} {{Saeedeh}} | ||
==Overview== | ==Overview== | ||
Hyponatremia is the most common electrolyte disturbances which is common with taking certain drugs and conditions. Screening the hyponatremia is necessary for preventing further decrease in serum sodium and complications of treatment. | |||
==Screening== | ==Screening== | ||
Plasma sodium should be check in | Plasma sodium should be check in | ||
* 1–2 weeks after initiation of [[Thiazides|thiazide]], [[Serotonin-norepinephrine reuptake inhibitor|SNRI]], and [[Selective serotonin reuptake inhibitor|SSRI]] therapy, especially in patients at high risk for hyponatremia | * 1–2 weeks after initiation of [[Thiazides|thiazide]], [[Serotonin-norepinephrine reuptake inhibitor|SNRI]], and [[Selective serotonin reuptake inhibitor|SSRI]] therapy, especially in patients at high risk for hyponatremia | ||
* All hospitalized patients on admission | * All hospitalized patients on admission | ||
* check plasma level daily in all patients with hyponatremia | |||
* Check plasma level in all patients with risk of hyponatremia | |||
To see the risk factors for developing hyponatremia, click [[Hyponatremia risk factors#Risk factors|here]]. | To see the risk factors for developing hyponatremia, click [[Hyponatremia risk factors#Risk factors|here]]. | ||
Revision as of 15:21, 1 June 2018
|
Hyponatremia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyponatremia screening On the Web |
|
American Roentgen Ray Society Images of Hyponatremia screening |
|
Risk calculators and risk factors for Hyponatremia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]
Overview
Hyponatremia is the most common electrolyte disturbances which is common with taking certain drugs and conditions. Screening the hyponatremia is necessary for preventing further decrease in serum sodium and complications of treatment.
Screening
Plasma sodium should be check in
- 1–2 weeks after initiation of thiazide, SNRI, and SSRI therapy, especially in patients at high risk for hyponatremia
- All hospitalized patients on admission
- check plasma level daily in all patients with hyponatremia
- Check plasma level in all patients with risk of hyponatremia
To see the risk factors for developing hyponatremia, click here.